Appointment booking for Dr. Matthew Cotant, MD is currently not available.Dr. Matthew Cotant, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Matthew Cotant, MD (he/him) is a Oncologist in Royal Oak, MI with over 17 years of experience. What is your opinion of Dr. Matthew Cotant, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Matthew Cotant, MD has received over $9,574 which includes payments from the following companies:
$1,380.32 from Genentech USA, Inc.
$1,168.14 from Novartis Pharmaceuticals Corporation
$815.88 from Amgen Inc.
$697.08 from E.R. Squibb & Sons, L.L.C.
$450.58 from Pfizer Inc.
$426.32 from sanofi-aventis U.S. LLC
$412.43 from AstraZeneca Pharmaceuticals LP
$305.39 from LILLY USA, LLC
$270.96 from Celgene Corporation
$255.52 from Merck Sharp & Dohme Corporation
$243.01 from Astellas Pharma US Inc
$222.57 from EMD Serono, Inc.
$215.43 from Janssen Biotech, Inc.
$210.91 from Medivation Inc.
$200.00 from COMSORT, Inc
$163.47 from AMAG Pharmaceuticals, Inc.
$157.13 from Janssen Pharmaceuticals, Inc
$157.00 from Eisai Inc.
$136.97 from Gilead Sciences Inc
$135.65 from GENZYME CORPORATION
Payments received by Dr. Matthew Cotant, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!